Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment

Silva, Rosiana Estéfane da; Carvalho, Janaína de Pina; Ramalho, Dario Brock; Senna, Maria Camilo Ribeiro De; Moreira, Hugo Silva Assis; Rabello, Ana; Cota, Erika; Cota, Gláucia.
Mem. Inst. Oswaldo Cruz ; 113(2): 71-79, Feb. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-894896

Documentos relacionados

  1. Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.
  2. Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
  3. Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre.
  4. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).
  5. A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis.
  6. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.
  7. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
  8. Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment.
  9. Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis.
  10. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.